Other Undergraduate 373 words

CRA Site Visit Planning: Agenda, Checklist & Outcomes

~2 min read

Abstract

This paper presents a comprehensive planning framework for a Clinical Research Associate (CRA) conducting an initial site visit to a major pharmaceutical firm. It outlines a full-day agenda coordinating introductions, protocol reviews, FDA compliance discussions, and concluding presentations. The document also specifies the desired outcomes of the visit, the materials that must be available on-site, the items the CRA must collect before departing, and the supplies the CRA should bring. Together, these components provide a practical operational guide for ensuring effective oversight of clinical trials at a pharmaceutical research site.

📝 How to Write This Type of Paper Writing guide — click to expand

▼

What makes this paper effective

Uses a clear, structured format with numbered lists and a timetabled agenda, making the plan easy to follow and implement in a professional setting.
Directly ties each section to a practical purpose — outcomes, required documents, and supplies are each addressed as distinct operational concerns.
Incorporates relevant citations to support the professional and regulatory context of the CRA role, lending academic credibility to a practice-oriented document.

Key academic technique demonstrated

This paper demonstrates applied professional writing — the ability to translate academic and regulatory knowledge into a concrete, actionable planning document. Rather than arguing a thesis, it organizes procedural information into a format suitable for real-world use, a skill valued in health sciences and clinical research administration programs.

Structure breakdown

The paper opens with a brief framing statement, then presents a timed agenda table covering the full visit day. Subsequent sections address desired outcomes, items that must be on-site, documents to collect before leaving, and supplies the CRA should bring. Each section is self-contained, using numbered lists for clarity. Two APA-formatted references anchor the document in published literature on CRA training and pharmaceutical career pathways.

Introduction and Purpose of the Site Visit

The following document outlines the planning framework for a Clinical Research Associate (CRA) conducting an initial site visit to a major pharmaceutical firm. It covers the visit agenda, desired outcomes, items that must be available on-site, documents to be collected, and supplies the CRA should bring.

The agenda presented below will be sent to the pharmaceutical firm in advance of the site visit.

CRA Site Visit Agenda

9:00–9:30 A.M. — Introductions and orientation

9:30–10:15 A.M. — Preliminary presentation to selected division chiefs and researchers concerning the CRA's role and responsibilities

10:15–10:30 A.M. — Break

10:30 A.M.–12:00 P.M. — Meetings with researchers and clinicians in their divisions concerning the purpose of clinical trials, relevant protocols, and controlling legislation

12:00–1:00 P.M. — Lunch

1:00–2:00 P.M. — Review of research to date and findings

2:00–3:00 P.M. — Meeting with the pharmaceutical firm's staff attorneys concerning U.S. Food and Drug Administration requirements for clinical trials (Jackson, 2007)

3:00–4:00 P.M. — Concluding presentation concerning the findings that emerged from the site visit

Desired Outcomes of the Visit

4:00–4:30 P.M. — Questions and answers

The initial site visit should provide the CRA with the background information needed to formulate appropriate areas for oversight and identify the principal individuals who are involved in the research.

Required Items at the Site and Documents to Collect

The following items should be available to the CRA during the initial visit:

1. Copies of all proposals and finalized studies for ongoing and planned clinical trials;
2. Findings from ongoing clinical trials; and
3. A roster of lead researchers and responsible executives (Hurst & Dennis, 2013).

The following information and items must be collected prior to the CRA's departure from the site:

1. An executed contract authorizing the CRA to perform oversight services for the pharmaceutical firm; and
2. Copies of the items listed above.

1 Locked Section · 45 words remaining

73% of this paper shown

Supplies to Bring to the Site · 45 words

"Materials CRA brings to the site visit"

130,000+ paper examplesAI writing assistantCitation generatorCancel anytime

Key Concepts in This Paper

CRA Site Visit Clinical Trials FDA Requirements Research Oversight Site Visit Agenda Pharmaceutical Firm Clinical Protocols Research Compliance CRA Training Trial Documentation